>

News

9 Aug
2022

Eleven Therapeutics Announces $22 Million in Seed Funding

Read More
24 Feb
2022

The virus mutates? We have the tools to fight back

Read More
18 Dec
2021

Eleven Therapeutics receives a notice of award from Innovate UK Smart Grants

Read More
7 Sep
2021

Eleven Therapeutics Appoints Prominent Biopharma Leader Dr. Iris Grossman as Chief Strategic Officer

Read More
1 Jul
2021

Eleven Therapeutics Receives $3.9 Million for Development of Innovative Treatments Against Respiratory Viruses

Read More
16 Dec
2020

Eleven Therapeutics Pursues Cooperative Research and Development (CRADA) with the National Institute of Allergy and Infectious Diseases in Fight Against Respiratory Viruses

Read More